EFV
Eva Fortea Verdejo Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
27%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
61.3%
Neutral
38.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $40 |
40%
upside
| 1 | -10% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $15 |
11%
downside
| 3 | +15% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $144 |
3%
downside
| 2 | +76% |
0
%
| 26 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $53 |
18%
upside
| 3 | +21% |
0
%
| 25 Feb ‘26 1 month ago |
|
|
|
Equal-Weight
Downgraded
| $23 |
5%
downside
| 4 | +40% |
0
%
| 12 Feb ‘26 2 months ago |
|
|
|
Equal-Weight
Maintained
| $35 |
22%
downside
| 1 | – |
–
| 11 Feb ‘26 2 months ago |
|
|
|
Overweight
Upgraded
| $33 |
19%
upside
| 4 | -5.2% |
0
%
| 12 Dec ‘25 4 months ago |
|
|
|
Equal-Weight
Maintained
| $11 |
54%
downside
| 3 | -33% |
0
%
| 11 Nov ‘25 5 months ago |
|
|
|
Overweight
Initiated
| $60 |
91%
upside
| 1 | -4.7% |
0
%
| 31 Oct ‘25 5 months ago |
|
|
|
Equal-Weight
Downgraded
| $97 |
8%
upside
| 4 | +40% |
0
%
| 30 Sep ‘25 6 months ago |
|
|
|
Equal-Weight
Maintained
| $11 |
8%
upside
| 4 | +9.8% |
0
%
| 7 Aug ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $27 |
107%
upside
| 1 | +64% |
0
%
| 7 Aug ‘25 8 months ago |
|
|
|
Overweight
Initiated
| $44 |
30%
upside
| 1 | +57% |
0
%
| 26 Jun ‘25 9 months ago |
|